SCHEMBL21392771

SCHEMBL21392771

IC(c1ccccc1)c1ccco1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.46
L3MBTL1 Q9Y468 4/20 0.42
POLB P06746 4/20 0.42
KMT2A Q03164 3/20 0.42
PKM P14618 1/20 0.42
PTPN1 P18031 1/20 0.42
PTPN7 P35236 1/20 0.42
BLM P54132 1/20 0.42
ESR2 Q92731 1/20 0.42
ALDH1A1 P00352 8/20 0.40
MAPT P10636 6/20 0.40
HPGD P15428 4/20 0.40
HSD17B10 Q99714 4/20 0.40
RECQL P46063 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
GLA P06280 1/20 0.40
MIF P14174 1/20 0.37
KDM4E B2RXH2 2/20 0.35
ALOX15 P16050 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8627683 0.76 CYP2C19 (0.48) CYP2C19L3MBTL1POLBKMT2APKM
SCHEMBL1934617 0.76 CYP2C19 (0.48) CYP2C19L3MBTL1POLBKMT2APKM
SCHEMBL3817995 0.74 CYP2C19 (0.47) CYP2C19L3MBTL1POLBKMT2APKM
SCHEMBL873428 0.74 DPP4 (0.47) LMNAMAPK1
SCHEMBL4523055 0.73 CYP2C19 (0.50) CYP2C19L3MBTL1POLBKMT2APKM
SCHEMBL17086734 0.73 ALDH1A1 (0.46) CYP2C19L3MBTL1POLBKMT2APKM
SCHEMBL10964536 0.73 CYP2C19 (0.50) CYP2C19L3MBTL1POLBKMT2APKM
SCHEMBL477450 0.73 L3MBTL1 (0.52) CYP2C19L3MBTL1POLBKMT2APKM
SCHEMBL477460 0.73 L3MBTL1 (0.52) CYP2C19L3MBTL1POLBKMT2APKM
SCHEMBL17086737 0.73 ALDH1A1 (0.46) CYP2C19L3MBTL1POLBKMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116946989-A Preparation method of phosphane/deuterated phosphane and derivatives thereof 北京大学 2023-10-27 CN disclosed
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 US disclosed
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY FRONTIER MEDICINES CORPORATION 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY ATG7, BECN1, SQSTM1 CYP2C19 4717/4885L3MBTL1 625/4885POLB 2880/4885
US-11666661-B2 Methods and compounds for targeted autophagy ATG7, BECN1, SQSTM1 CYP2C19 4717/4885L3MBTL1 625/4885POLB 2880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.